CoChat

Anti-inflammatory effects of melatonin: A systematic review and meta-analysis of clinical trials

Open access
Cho, Joshua H., Bhutani, Saumya, Kim, Carole H., Irwin, Michael R. · 2021 · Brain, Behavior, and Immunity
Cited by 168

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Chronic inflammation contributes to multiple diseases including cardiovascular diseases, autoimmune disorders, metabolic disorders, and psychiatric conditions. Melatonin, a hormone responsible for circadian rhythm, plays a complex role within the immune system, including having an anti-inflammatory effect. While there are numerous animal studies demonstrating this effect, few human clinical trials have been conducted. This systematic review of clinical trials examined whether exogenous melatonin reduces levels of inflammatory markers in humans. We searched PubMed, Embase, Cochrane Library, Scopus, and PsycINFO, and the references of the identified articles for randomized and non-randomized placebo-controlled trials. Data were extracted from the articles and meta-analyses were conducted using a random effects model to calculate standardized mean differences (SMDs, i.e., Cohen’s d). From an initial search result of 4548 references, 31 studies met the inclusion criteria and were included involving 1517 participants. Melatonin had significant anti-inflammatory effects on interleukin (IL)-1 (SMD −1.64; 95% confidence interval [CI] −2.86, −0.43; p=0.008), IL-6 (−3.84; −5.23, −2.46; p<0.001), IL-8 (−21.06; −27.27, −14.85; p<0.001), and tumor necrosis factor (TNF) (−1.54; −2.49, −0. 58; p=0.002), but not on C-reactive protein (CRP) (−0.18; −0.91, 0.55; p=0.62). Trimming outlier studies with large effect sizes eliminated publication bias, and summary effect sizes were significant for IL-1 (SMD −1.11; 95% CI −1.90, −0.32; p=0.006), IL-6 (−1.91; −2.98, −0.83; p=0.001), and IL-8 (−13.46; −18.88, −8.04; p<0.001), but not for TNF (−0.45; −1.13, 0.23; p=0.19). Exogenous melatonin reduced levels of inflammatory markers and may be useful for prevention and adjuvant treatment of inflammatory disorders. Melatonin is safe with few side effects, which makes it an excellent agent for prevention of inflammatory disorders. Because chronic inflammation increases with aging and inflammation plays a role in the etiology of numerous diseases that affect older populations, melatonin has the potential to be widely used particularly in older adults.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbi.2021.01.034

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 8 references

Cited by

See all 168

Metadata

Authors
Cho, J. H., Bhutani, S., Kim, C. H., & Irwin, M. R.
Venue
Brain, Behavior, and Immunity
Publisher
Elsevier BV
Published
2021-03
Volume
93
Pages
245-253
ISSN
0889-1591 (ISSN-L)
OpenAlex
W3128092763
Cited by
168
References
8
FWCI
3.29
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anti-inflammatory effects of melatonin: A systematic review and meta-analysis of clinical trials. https://app.cochat.ai/papers/10.1016/j.bbi.2021.01.034
The paper
Cho, J. H., Bhutani, S., Kim, C. H., & Irwin, M. R. (2021). Anti-inflammatory effects of melatonin: A systematic review and meta-analysis of clinical trials. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2021.01.034

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.